Cipla plans to invest in UK subsidiary
07/07/2014 18:02
Leading drug maker Cipla Ltd on Monday said the company, in collaboration with the UK government, has expressed its intention to make investments of up to EUR 100 million in its UK subsidiary over the next few years. Further, the investments are expected to facilitate the launch of a range of products in the area of respiratory, oncology and antiretroviral medicines to further company’s higher purpose of ‘universal affordable access’. In a filing to the Bombay Stock Exchange, the company informed, “The company, in collaboration with the UK government, has expressed its intention to make investments of up to EUR 100 million in its UK subsidiary over the next few years.” After hitting a 52 week high, shares of the company closed at Rs 449.30 a piece, up 0.31 per cent, from previous close on BSE.
07/07/2014 18:02
Leading drug maker Cipla Ltd on Monday said the company, in collaboration with the UK government, has expressed its intention to make investments of up to EUR 100 million in its UK subsidiary over the next few years. Further, the investments are expected to facilitate the launch of a range of products in the area of respiratory, oncology and antiretroviral medicines to further company’s higher purpose of ‘universal affordable access’. In a filing to the Bombay Stock Exchange, the company informed, “The company, in collaboration with the UK government, has expressed its intention to make investments of up to EUR 100 million in its UK subsidiary over the next few years.” After hitting a 52 week high, shares of the company closed at Rs 449.30 a piece, up 0.31 per cent, from previous close on BSE.
